These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
242 related articles for article (PubMed ID: 24666673)
1. Natural modulators of liver X receptors. Huang C J Integr Med; 2014 Mar; 12(2):76-85. PubMed ID: 24666673 [TBL] [Abstract][Full Text] [Related]
2. The liver X receptor: control of cellular lipid homeostasis and beyond Implications for drug design. Oosterveer MH; Grefhorst A; Groen AK; Kuipers F Prog Lipid Res; 2010 Oct; 49(4):343-52. PubMed ID: 20363253 [TBL] [Abstract][Full Text] [Related]
3. Liver X receptor: a cardinal target for atherosclerosis and beyond. Parikh M; Patel K; Soni S; Gandhi T J Atheroscler Thromb; 2014; 21(6):519-31. PubMed ID: 24695022 [TBL] [Abstract][Full Text] [Related]
4. Liver X receptors as potential therapeutic targets in atherosclerosis. Zhu Y; Li Y Clin Invest Med; 2009 Oct; 32(5):E383-94. PubMed ID: 19796580 [TBL] [Abstract][Full Text] [Related]
5. Selective liver X receptor modulators (SLiMs): what use in human health? Viennois E; Mouzat K; Dufour J; Morel L; Lobaccaro JM; Baron S Mol Cell Endocrinol; 2012 Apr; 351(2):129-41. PubMed ID: 21907760 [TBL] [Abstract][Full Text] [Related]
6. Liver X receptor is a regulator of orphan nuclear receptor NOR-1 gene transcription in adipocytes. Kumar N; Wang H; Liu D; Collins S Int J Obes (Lond); 2009 May; 33(5):519-24. PubMed ID: 19238156 [TBL] [Abstract][Full Text] [Related]
7. Liver X receptor modulators: a review of recently patented compounds (2009 - 2012). Loren J; Huang Z; Laffitte BA; Molteni V Expert Opin Ther Pat; 2013 Oct; 23(10):1317-35. PubMed ID: 23826715 [TBL] [Abstract][Full Text] [Related]
8. Liver X receptor modulators: effects on lipid metabolism and potential use in the treatment of atherosclerosis. Fiévet C; Staels B Biochem Pharmacol; 2009 Apr; 77(8):1316-27. PubMed ID: 19101522 [TBL] [Abstract][Full Text] [Related]
9. Liver X receptor biology and pharmacology: new pathways, challenges and opportunities. Jakobsson T; Treuter E; Gustafsson JÅ; Steffensen KR Trends Pharmacol Sci; 2012 Jul; 33(7):394-404. PubMed ID: 22541735 [TBL] [Abstract][Full Text] [Related]
10. Targeting liver X receptors in human health: deadlock or promising trail? Viennois E; Pommier AJ; Mouzat K; Oumeddour A; El Hajjaji FZ; Dufour J; Caira F; Volle DH; Baron S; Lobaccaro JM Expert Opin Ther Targets; 2011 Feb; 15(2):219-32. PubMed ID: 21204733 [TBL] [Abstract][Full Text] [Related]
11. Liver X receptor (LXR) and the reproductive system--a potential novel target for therapeutic intervention. Bełtowski J; Semczuk A Pharmacol Rep; 2010; 62(1):15-27. PubMed ID: 20360612 [TBL] [Abstract][Full Text] [Related]
12. Liver X receptors, atherosclerosis and inflammation. Michael DR; Ashlin TG; Buckley ML; Ramji DP Curr Atheroscler Rep; 2012 Jun; 14(3):284-93. PubMed ID: 22419222 [TBL] [Abstract][Full Text] [Related]
13. Action mechanisms of Liver X Receptors. Gabbi C; Warner M; Gustafsson JÅ Biochem Biophys Res Commun; 2014 Apr; 446(3):647-50. PubMed ID: 24300092 [TBL] [Abstract][Full Text] [Related]
14. Functional crosstalk of CAR-LXR and ROR-LXR in drug metabolism and lipid metabolism. Xiao L; Xie X; Zhai Y Adv Drug Deliv Rev; 2010 Oct; 62(13):1316-21. PubMed ID: 20659512 [TBL] [Abstract][Full Text] [Related]
15. Biological mechanisms and related natural modulators of liver X receptor in nonalcoholic fatty liver disease. Ni M; Zhang B; Zhao J; Feng Q; Peng J; Hu Y; Zhao Y Biomed Pharmacother; 2019 May; 113():108778. PubMed ID: 30897538 [TBL] [Abstract][Full Text] [Related]
16. Therapeutic opportunities for liver X receptor modulators. Collins JL Curr Opin Drug Discov Devel; 2004 Sep; 7(5):692-702. PubMed ID: 15503871 [TBL] [Abstract][Full Text] [Related]
17. Transcriptional and posttranscriptional control of cholesterol homeostasis by liver X receptors. Tontonoz P Cold Spring Harb Symp Quant Biol; 2011; 76():129-37. PubMed ID: 21859674 [TBL] [Abstract][Full Text] [Related]
18. Activation of liver X receptor improves glucose tolerance through coordinate regulation of glucose metabolism in liver and adipose tissue. Laffitte BA; Chao LC; Li J; Walczak R; Hummasti S; Joseph SB; Castrillo A; Wilpitz DC; Mangelsdorf DJ; Collins JL; Saez E; Tontonoz P Proc Natl Acad Sci U S A; 2003 Apr; 100(9):5419-24. PubMed ID: 12697904 [TBL] [Abstract][Full Text] [Related]
19. The human ADFP gene is a direct liver-X-receptor (LXR) target gene and differentially regulated by synthetic LXR ligands. Kotokorpi P; Venteclef N; Ellis E; Gustafsson JA; Mode A Mol Pharmacol; 2010 Jan; 77(1):79-86. PubMed ID: 19843633 [TBL] [Abstract][Full Text] [Related]
20. Liver X receptor modulators: a review of recently patented compounds (2007 - 2009). Li X; Yeh V; Molteni V Expert Opin Ther Pat; 2010 Apr; 20(4):535-62. PubMed ID: 20302451 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]